MedPath

The efficacy of Omega-3 fatty acids (Omegaven) for patients with liver disease secondary to intestinal failure

Not Applicable
Conditions
intestinal failure associated liver disease
Registration Number
JPRN-UMIN000020159
Lead Sponsor
Keio University School of Medicine, Department of Pediatric Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Conditions including severe infections, poorly controlled diabetes, shock, coagulopathy, fat metabolism disorder, allergic to fish or eggs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath